Loading clinical trials...
Loading clinical trials...
Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD
Conditions
Interventions
Exposure & Response Prevention (EX/RP)
Locations
2
United States
New York State Psychiatric Institute
New York, New York, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
June 15, 2022
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
October 7, 2025
NCT06647589
NCT05843604
NCT05580614
NCT06763081
NCT06720090
NCT06983301
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions